Skip to main content Help with accessibility Skip to main navigation

RIFAXIMIN 550mg tablets (Targaxan®▼)

CCG Approval Status:

Date Added: 26 - Jul - 2017
Amber retained

The Pan Mersey Area Prescribing Committee recommends RIFAXIMIN 550mg tablets (Targaxan®), following specialist initiation, as an option for reducing the recurrence of overt hepatic encephalopathy in people aged 18 years or older in accordance with NICE TA 337.